In the 51 patients with EGFR mutation detected in the tumor tissue, 33 (65%) patients had concordant EGFR mutation test results in liquid biopsy, while 18 (35%) patients had discordant results (Figure 1, Table 1). Here, EGFR is linked to neoplasm.